Doxazosin for the management of hypertension: implications of the findings of the ALLHAT trial

Am J Hypertens. 2001 Nov;14(11 Pt 1):1170-2. doi: 10.1016/s0895-7061(01)02212-9.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adrenergic alpha-Antagonists / adverse effects
  • Adrenergic alpha-Antagonists / therapeutic use*
  • Antihypertensive Agents / adverse effects
  • Antihypertensive Agents / therapeutic use*
  • Clinical Trials as Topic
  • Doxazosin / adverse effects
  • Doxazosin / therapeutic use*
  • Humans
  • Hypertension / drug therapy*
  • Treatment Outcome

Substances

  • Adrenergic alpha-Antagonists
  • Antihypertensive Agents
  • Doxazosin